CLINICAL_TRIALS
trial_result
· 2013-10-11
Clinical Trial Update: Safety and Efficacy Study of Osmotic Release Oral System (OROS) Hydromorphone in Participants With Cancer Pain [Phase 4]
Summary
A Phase 4 safety and efficacy study of OROS hydromorphone for cancer-related pain was terminated, with results posted in 2013.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Janssen Pharmaceutica | Conditions: Pain | Phase 4 | Status: TERMINATED | Results posted: 2013-10-11